Home > News > Spire to develop technology for orthopedic prostheses
August 12th, 2003
Spire to develop technology for orthopedic prostheses
Spire Corp. has received a two-year, $750,000 SBIR Phase II grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to develop nanotechnology coatings. Under the grant, Spire will develop hard, extremely adherent nanocrystalline coatings for orthopedic implants. The coatings contain metallic bonding and have a chemical composition very similar to the substrate. Feasibility of the technology was demonstrated during a Phase I grant.
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014
Nanometrics Announces Upcoming Investor Events July 22nd, 2014
Harris & Harris Group Invests in UberSeq, Inc. July 16th, 2014
Harris & Harris Group Portfolio Company D-Wave Systems Closes a $28.4 Million Financing July 14th, 2014